InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Burkly Linda. Director active across 1 company, notably Editas Medicine, Inc.. Cumulatively, 12 reports have been logged. Breakdown: 0 buy · 10 sells. Total volume traded: €96k. History available since 24 July 2023. The latest transaction was disclosed on 3 September 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 条申报中的 12 条
Burkly Linda is EVP, CHIEF SCIENTIFIC OFFICER at Editas Medicine, Inc. She has 11 filings, all in the available sample, with EUR 0 in buys and EUR 93762 in sells over the period from 2023-07-25 to 2026-07-29. The modal transaction nature is Cession.